Molecular pathogenesis of cutaneous lymphoma-Future directions

Area of Science:

• Oncology
• Genetics
• Immunology

Background:

• The pathogenesis of cutaneous T-cell lymphoma (CTCL) remains incompletely understood.
• Genetic alterations, including copy number variations (CNV) and single nucleotide variations (SNV), exhibit significant patient-to-patient heterogeneity.
• Key signaling pathways implicated in CTCL include JAK-STAT, MAPK, T-cell receptor, TNF receptor, and NFκB.

Purpose of the Study:

• To review and synthesize recent findings on genetic changes in CTCL.
• To explore the evolving landscape of genetic analysis in CTCL, including the shift towards whole-genome sequencing.
• To identify recurrently mutated pathways and non-coding regions relevant to CTCL pathogenesis.

Main Methods:

• Review of recent scientific literature on CTCL genetics.
• Analysis of studies documenting copy number variations (CNV) and single nucleotide variations (SNV).
• Exploration of genetic alterations in gamma delta T-cell lymphoma.

Main Results:

• CTCL exhibits substantial genetic heterogeneity with mutations in multiple signaling pathways.
• Recent studies confirm recurrent mutations in JAK-STAT, MAPK, MYC, and chromatin signaling pathways, particularly in gamma delta T-cell lymphoma.
• Whole-genome sequencing is emerging as a valuable approach, revealing mutations in non-coding regulatory regions.

Conclusions:

• Understanding the diverse genetic landscape of CTCL is crucial for elucidating its pathogenesis.
• The identification of specific molecular alterations in signaling pathways provides a basis for developing targeted therapies.
• Advances in sequencing technologies, including whole-genome sequencing, offer new avenues for discovering actionable mutations in CTCL.